2022 International Congress Archives - Page 10 of 153

ADOPTION Study: Status update of a Randomised, Open-Label Exploratory Trial of Opicapone in Parkinson’s Disease

J. Ferreira, W. Poewe, O. Rascol, F. Stocchi, A. Antonini, R. Costa, D. Magalhães, J. Rocha, P. Soares-da-Silva (Lisbon, Portugal)
Adrenergic blockers and statins are associated with later age of onset in Parkinson’s disease

C. Malatt, I. Khatiwala, M. Rangwala, A. Maleki, E. Hogg, E. Tan, M. Tagliati (Los Angeles, USA)
ADS024 attenuates striatal dopamine loss and restores movement in animal models of Parkinson’s disease

L. Chesnel, S. Acton (Concord, USA)
Adult-onset Alexander’s disease – New causal mutation in GFAP gene

T. Goerttler, L. Zanetti, M. Regoni, K. Egger, E. Kellner, C. Deuschl, C. Kleinschnitz, J. Sassone, S. Klebe (Essen, Germany)
Adult-onset axial dystonia: a rare condition that can lean on an early combined treatment approach

P. Mitrotti, G. Vaghi, V. Grillo, C. Susca, R. de Icco, M. Allena, M. Avenali, C. Tassorelli (Pavia, Italy)
Adults with slowly progressive dystonia-parkinsonism secondary to manganese accumulation

R. Dayan, E. Linetzky, H. Mor-Shaked, M. Bauer, C. Muller, D. Arkadir (Jerusalem, Israel)
Advance Care Planning and Parkinson’s disease: patient knowledge assessment

B. Rodrigues, E. Cournean, N. Prakash, D. Costello, K. Badiola, C. Selvadurai (Farmington, USA)
Adverse drug reactions to apomorphine: a worldwide pharmacovigilancedatabase analysis

M. Auffret, C. Le Corre, LM. Scailteux, M. Vérin, E. Polard (Rennes, France)
Aerobic glycolysis regulates microglia-mediated neuroinflammation by promoting H3K9 lactylation in Parkinson’s disease

Q. Qixiong, W. Hengming, W. Danlei, L. Jingyi, Q. Yi, Z. Jingwei, L. Jiangting (wuhan, China)
Affected tongue movements in idiopathic REM sleep behavior disorder

T. Thies, N. Geerts, D. Mücke, A. Seger, M. Barbe, M. Sommerauer (Cologne, Germany)